Life Sciencedagen 2024
ฝัง
- เผยแพร่เมื่อ 2 ต.ค. 2024
- Cereno presented at Life Sciencedagen, March 6 2024, in Gothenburg
CEO Sten R. Sörensen and CMO and Head of R&D Rahul Agrawal, presented the company portfolio, the role of HDAC inhibition and disease-modifying properties of CS1 in PAH, gave an overview of thrombosis prevention with CS014, and an introduction to the preclinical program CS585.